SCIENCE WITH A PURPOSE
Therapies across cardiovascular conditions, backed by our expertise in pharmaceutical development.
Central nervous system portfolio addressing neurological and psychiatric conditions.
Inhalation and systemic therapies restoring airflow and managing chronic respiratory conditions.
A portfolio of therapies addressing key urological conditions and prostate care.
A growing portfolio addressing kidney-related conditions, renal transplant and evolving treatment needs.
A focused portfolio of therapies addressing a range of musculoskeletal conditions.
Disease-modifying anti-rheumatic therapies improving mobility and joint outcomes.
Proton pump inhibitors, prokinetics, and mucosal protectors for gastrointestinal health.
Holistic formulations supporting maternal well-being, prenatal care, and pediatric recovery.
Nutritional supplementation formulations combating micronutrient deficiencies.
Standardized botanical extract formulations accelerating platelet count recovery in viral fevers.
Topical and systemic dermatological formulations for chronic skin conditions and infections.
High-acuity injectable antibiotics and critical hospital therapeutics for intensive care settings.
Broad-spectrum primary care anti-infectives, antipyretics, and essential internal medicine formulations.
Advanced analgesic formulations, non-steroidal anti-inflammatory agents, and multi-modal pain therapies for acute and chronic pain management.
Therapies across cardiovascular conditions, backed by our expertise in pharmaceutical development.
Inhalation and systemic therapies restoring airflow and managing chronic respiratory conditions.
A portfolio of therapies addressing key urological conditions and prostate care.
A growing portfolio addressing kidney-related conditions, renal transplant and evolving treatment needs.
A focused portfolio of therapies addressing a range of musculoskeletal conditions.
Disease-modifying anti-rheumatic therapies improving mobility and joint outcomes.
Proton pump inhibitors, prokinetics, and mucosal protectors for gastrointestinal health.
Holistic formulations supporting maternal well-being, prenatal care, and pediatric recovery.
Nutritional supplementation formulations combating micronutrient deficiencies.
Standardized botanical extract formulations accelerating platelet count recovery in viral fevers.
Topical and systemic dermatological formulations for chronic skin conditions and infections.
High-acuity injectable antibiotics and critical hospital therapeutics for intensive care settings.
Broad-spectrum primary care anti-infectives, antipyretics, and essential internal medicine formulations.
Advanced analgesic formulations, non-steroidal anti-inflammatory agents, and multi-modal pain therapies for acute and chronic pain management.
THE BRANDS BEHIND CARE
FROM EXPERTISE TO EDGE
From AI-enabled automation to digitally powered customer engagement, we're rethinking how our teams work, connect and deliver.
FDA, WHO-GMP and EU-GMP certified facilities, with rigorous quality standards built into every stage.
From early discovery to regulatory filing, our integrated R&D capabilities translate scientific insight into promising therapies.
ONE ORIGIN. MANY HORIZONS.
Our global presence
Hover overTap a highlighted country on the globe to see our centre and what we do there.
Partnering with global pharmaceutical innovators through advanced synthetic chemistry, US FDA & EU GMP audited manufacturing, and dependable worldwide supply.
Complex synthetic chemistry, high-potency molecules and custom scale-up synthesis.
Certified by premier global regulatory agencies with comprehensive DMF and CEP filings.
Supplying regulated markets across North America, Europe, Latin America and Asia.
Fast-track technical transfer, commercial sample requests and custom CDMO collaboration.
Real-time equity market performance, audited financial statements, shareholder services, and statutory SEBI LODR Regulation 46 disclosures.
Access audited annual reports, quarterly filings, and investor presentations.
RPG Life Sciences is committed to creating enduring value, maintaining rigorous corporate governance, and delivering transparent shareholder communications.
IN THE MOMENT
RPG Life Sciences Ltd's wholly-owned subsidiary, RPG Active Pharma Ltd, has entered into a business transfer agreement to acquire...
Read more
The company has signed an agreement to transfer the API business to wholly owned subsidiary RPG Active Pharma Ltd.
Read more
A landmark milestone in the company's 2030 net-zero roadmap for all global manufacturing sites.
Read more
HOW WE SHOW UP
We believe progress should be shared. That means investing in the communities around us and making choices that are better for the world we all share.
Bring your expertise, curiosity and ambition to a team shaping what's next in life sciences. Here, your ideas have room to grow, and your work has a place in something bigger.
